US subsidiary of Glenmark, Glenmark Generics has announced that it has settled all litigation pending between Glenmark and Medicis. The litigation were regarding the patent actions of Fluocinonide, the generic version of Medicis’ Vanos cream and Ciclopirox Olamine, the generic version of Medicis Loprox gel.
Under the terms of the agreement, Glenmark will now be able to market and distribute its generic version of Vanos cream under license from Medicis. Glenmark plans to start distribution as early as December 2013.
Furthermore, Glenmark will also receive license to launch generic version of Loprox gel 0.77%, currently supplied by Medicis.